Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

- PMLiVE

Roche announces CHMP recommendation for PiaSky in rare blood condition PNH

Paroxysmal nocturnal haemoglobinuria affects approximately 20,000 people worldwide

- PMLiVE

Almirall’s Ilumetri shown to improve and maintain well-being in plaque psoriasis patients

Nearly 77% of psoriasis patients report that the condition negatively affects their well-being

- PMLiVE

Find your brand’s edge, with dynamic competitive simulations

How the best teams in pharma stay at the top of their game

- PMLiVE

Johnson & Johnson’s Rybrevant granted EC approval for first-line NSCLC use

The drug was previously approved by the EU regulator for use after the failure of platinum-based therapy

- PMLiVE

Pfizer/BioNTech’s Omicron JN.1-adapted COVID-19 vaccine recommended by CHMP

The vaccine generated an improved response against several Omicron JN.1 sublineages

- PMLiVE

AbbVie announces CHMP recommendation for Tepkinly in follicular lymphoma

The blood cancer accounts for up to 30% of all non-Hodgkin lymphoma cases

- PMLiVE

Savara announces positive phase 3 results for molgramostim in rare lung disease

Autoimmune pulmonary alveolar proteinosis affects around one in every 150,000 people in the US

- PMLiVE

Taking a more mindful approach to meetings

Having a break between meetings can improve our well-being and the quality of our work

- PMLiVE

NICE recommends CSL Behring’s haemophilia B gene therapy Hemgenix

More than 2,000 people in the UK are currently living with the genetic bleeding disorder

- PMLiVE

AbbVie expands inflammatory disease pipeline with $250m Celsius acquisition

The deal includes an anti-TREM1 antibody that has completed a phase 1 study in inflammatory bowel disease

- PMLiVE

FDA publishes guidance on diversity action plans to improve enrolment in clinical trials

The guidance will help to enhance the understanding of a disease or medical product being studied

- PMLiVE

Scientists discover new form of gene editing to recombine and rearrange DNA

The bridge RNA system allows researchers to edit, delete and convert DNA recombinases without using CRISPR

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links